Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes

NCT07227805 is registered in ClinicalTrials.gov with Medtronic MiniMed, Inc. as lead sponsor.

NCT NCT07227805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07227805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes
Lead sponsor
Medtronic MiniMed, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
July 19, 2026
Completion date
March 17, 2027
Enrollment
116 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes (insulin-requiring, type 1 or type 2)